1. Comis, R.L.: DTIC (NSC-45388) in malignant melanoma: A perspective. Cancer Treat. Rep.60:165, 1976
2. Balch, C.M., Houghton, A.N., Peters, L.: Cutaneous melanoma. In Cancer: Principles and Practices of Oncology, V.T. DeVita, S. Hellman, S.A. Rosenberg, editors, Philadelphia, Lippincott, 1989, pp. 1499–1542
3. Pritchard, K.I., Quirt, C.I., Cowan, D.H., Osoba, D., Kutas, G.J.: DTIC therapy in metastatic malignant melanoma: A simplified dose schedule. Cancer Treat. Rep.64:1123, 1980
4. Glover, D., Glick, J.H., Weiler, C., Fox, K., Grabelsky, S., Guerry, D.: High dose cis-platinum (DDP) and WR-2721 (WR) in metastatic melanoma (abstract). Proc. Am. Soc. Clin. Oncol.7:A956, 1988
5. Del Prete, S.A., Maurer, L.H., O'Donnell, J., Forcier, R.J., LeMarbre, P.: Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat. Rep.68:1403, 1984